{"id":"W2024593618","doi":"10.1097/01.jto.0000283140.60799.58","title":"B1-02: A Phase 1-2 study of the anti-sense oligonucleotide OGX-011 in combination with a platinum/gemcitabine regimen as first-line therapy for advanced non-small cell lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Regional Cancer Foundation; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Chemotherapy; Regimen; Docetaxel; Internal medicine; Oncology; Clusterin; Cisplatin; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001435594,0.0002423868,0.0009443323,0.0003906718,0.0000795177,0.000006674723,0.0002296293,0.0001599055,0.00004680047],"category_scores_gemma":[0.0002455249,0.0001602079,0.0001564853,0.0004440945,0.0001280995,0.00009804685,0.00007239295,0.0004794372,7.920897e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004349368,"about_ca_system_score_gemma":0.0005354102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006385879,"about_ca_topic_score_gemma":0.0006906343,"domain_scores_codex":[0.997755,0.0002073677,0.001067041,0.000268003,0.0003261994,0.0003763988],"domain_scores_gemma":[0.9968311,0.0005864004,0.001438215,0.000377741,0.0006100974,0.0001564876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2559701,0.05601028,0.3133227,0.001527895,0.001396042,0.006449478,0.02750328,0.006477845,0.1458665,0.00003089371,0.001172813,0.1842722],"study_design_scores_gemma":[0.1945866,0.1376337,0.5528321,0.002159127,0.002734548,0.003885068,0.01183429,0.003954869,0.08605863,0.0003261159,0.003200247,0.0007946736],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927883,0.0007373164,0.0009364036,0.00212613,0.0005064412,0.002568721,0.00001137721,0.00001067569,0.0003146513],"genre_scores_gemma":[0.9962219,0.0001945538,0.002666359,0.0004298699,0.0001959745,0.00006481306,0.000003465288,0.00004743399,0.000175603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2395094,"threshold_uncertainty_score":0.653309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02335798420310963,"score_gpt":0.4157308660414288,"score_spread":0.3923728818383192,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}